Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | and similar dates through November 2027

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; max project period 2 years.

Summary: Supports exploratory/developmental bioengineering research to demonstrate feasibility and potential utility of new or improved solutions for biomedical, pre-clinical, or clinical research and care; clinical trials are not allowed.

Key Information: Limited submission: each application must be scientifically distinct; foreign organizations are eligible; clinical trials are not permitted.